Silverman Lou
Director at STAA; Director at QUESTCOR PHARMACEUTICALS INC; Chief Executive Officer at NEXTGEN HEALTHCARE, INC.
- Sold, on record
- $11M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 3
- Filed as an executive or holder
Companies
- STAASTAAR SURGICAL CODirector
- QUESTCOR PHARMACEUTICALS INCDirector
- NEXTGEN HEALTHCARE, INC.Chief Executive Officer
Sales by reason
0
Routine
1
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- NEXTGEN HEALTHCARE, INC.85,000 shares
- STAA53,917 shares
- QUESTCOR PHARMACEUTICALS INC10,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- Aug 10, 2021Unusual
Sold 91.1% of their holdings
$4.4M29,921 shares at $145.56
- Mar 1, 2021Unusual
Sold 91.9% of their holdings
$2.5M23,996 shares at $104.78
- Apr 7, 2014Unusual
Sold 41.4% of their holdings
$846k10,000 shares at $84.57
- Jun 12, 2007Plan not stated
Sold 7.3% of their holdings
$104k2,700 shares at $38.38
- Jun 12, 2007Unusual
Sold 70.5% of their holdings
$3.2M82,300 shares at $39.03
5 of 5
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 6, 2026 | IMDX | Director | Withheld for tax | 7,700 | $5.69 | $44k | 55,807 | SEC |
| Jun 18, 2026 | Jun 22, 2026 | STAA | Director | Exercised or settledRestricted Stock Units | 10,683 | 0 | SEC | ||
| Jun 18, 2026 | Jun 22, 2026 | STAA | Director | Exercised options | 10,683 | 11,158 | SEC | ||
| Jun 18, 2026 | Jun 22, 2026 | STAA | Director | AwardedRestricted Stock Units | 6,182 | 6,182 | SEC | ||
| Jun 11, 2026 | Jun 15, 2026 | IMDX | Director | Awarded | 26,943 | 63,507 | SEC | ||
| Jun 1, 2026 | Jun 3, 2026 | ALLSCRIPTS HEALTHCARE SOLUTIONS INC | Director | Awarded | 42,507 | 99,131 | SEC | ||
| Jul 1, 2025 | Jul 3, 2025 | IMDX | Director | Awarded | 35,000 | 36,564 | SEC | ||
| Jun 18, 2025 | Jun 20, 2025 | STAA | Director | AwardedRestricted Stock Units | 10,683 | 10,683 | SEC | ||
| Jun 2, 2025 | Jun 3, 2025 | ALLSCRIPTS HEALTHCARE SOLUTIONS INC | Director | Awarded | 46,512 | $4.30 | $200k | 56,624 | SEC |
| May 12, 2025 | May 13, 2025 | STAA | Director | AwardedCommon Stock Options | 2,440 | 2,440 | SEC | ||
| Mar 24, 2025 | Mar 26, 2025 | ALLSCRIPTS HEALTHCARE SOLUTIONS INC | Director | Awarded | 10,112 | 10,112 | SEC | ||
| Jul 1, 2024 | Jul 3, 2024 | IMDX | Director | AwardedOption to Purchase Common Stock | 30,000 | 30,000 | SEC | ||
| Jun 23, 2023 | Jun 27, 2023 | IMDX | Director | AwardedOption to Purchase Common Stock | 112,500 | 112,500 | SEC | ||
| Jun 23, 2023 | Jun 27, 2023 | IMDX | Director | Awarded | 25,000 | 31,270 | SEC | ||
| Aug 10, 2021 | Aug 12, 2021 | STAA | Director | Sold | 29,921 | $145.56 | $4.4M | 2,924 | SEC |
| Aug 10, 2021 | Aug 12, 2021 | STAA | Director | Exercised or settledCommon Stock Options | 29,921 | 0 | SEC | ||
| Aug 10, 2021 | Aug 12, 2021 | STAA | Director | Exercised options | 29,921 | $9.09 | $272k | 12,845 | SEC |
| Jun 24, 2021 | Jun 25, 2021 | STAA | Director | Exercised options | 807 | 2,924 | SEC | ||
| Mar 1, 2021 | Mar 3, 2021 | STAA | Director | Sold | 23,996 | $104.78 | $2.5M | 2,117 | SEC |
| Jul 30, 2020 | Aug 4, 2020 | STAA | Director | Awarded | 2,117 | 15,850 | SEC | ||
| Jun 20, 2019 | Jun 24, 2019 | STAA | Director | AwardedCommon Stock Options | 4,268 | 4,268 | SEC | ||
| Jun 20, 2019 | Jun 24, 2019 | STAA | Director | Awarded | 2,127 | 13,733 | SEC | ||
| Jun 14, 2018 | Jun 18, 2018 | STAA | Director | AwardedCommon Stock Options | 7,155 | 7,155 | SEC | ||
| Mar 15, 2018 | Mar 19, 2018 | STAA | Director | AwardedCommon Stock Options | 1,206 | 1,206 | SEC | ||
| Jun 13, 2017 | Jun 15, 2017 | STAA | Director | AwardedCommon Stock Options | 9,921 | 9,921 | SEC | ||
| Jun 13, 2017 | Jun 15, 2017 | STAA | Director | Awarded | 5,208 | 11,606 | SEC | ||
| Oct 27, 2016 | Oct 31, 2016 | COMARCO INC | Director | AwardedRight to buy | 74,048 | 50,000 | SEC | ||
| Aug 8, 2016 | Aug 10, 2016 | STAA | Director | AwardedCommon Stock Options | 10,000 | 10,000 | SEC | ||
| Jun 24, 2016 | Jun 27, 2016 | STAA | Director | AwardedCommon Stock Options | 20,000 | 20,000 | SEC | ||
| Aug 10, 2015 | Aug 11, 2015 | STAA | Director | Bought | 1,500 | $8.18 | $12k | 6,398 | SEC |
| Jul 8, 2015 | Jul 10, 2015 | STAA | Director | AwardedCommon Stock Options | 10,000 | 10,000 | SEC | ||
| Jul 8, 2015 | Jul 10, 2015 | STAA | Director | Awarded | 4,898 | 4,898 | SEC | ||
| Jun 17, 2015 | Jun 19, 2015 | COMARCO INC | Director | AwardedRight to buy | 25,952 | 25,952 | SEC | ||
| Sep 15, 2014 | Sep 16, 2014 | STAA | Director | Awarded | 11,763 | 11,763 | SEC | ||
| Aug 14, 2014 | Aug 18, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Returned to the companyStock Option (right to buy) | 89,104 | 0 | SEC | ||
| Aug 14, 2014 | Aug 18, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Returned to the company | 24,183 | 0 | SEC | ||
| Apr 7, 2014 | Apr 9, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Sold | 10,000 | $84.57 | $846k | 14,183 | SEC |
| Apr 7, 2014 | Apr 9, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Exercised or settledStock Option (right to purchase) | 10,000 | 6,667 | SEC | ||
| Apr 7, 2014 | Apr 9, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Exercised options | 10,000 | $4.08 | $41k | 24,183 | SEC |
| Oct 8, 2013 | Oct 10, 2013 | COMARCO INC | Director | Awarded | 75,000 | 75,000 | SEC | ||
| May 24, 2013 | May 29, 2013 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedStock Option (right to purchase) | 9,203 | 9,203 | SEC | ||
| May 24, 2013 | May 29, 2013 | QUESTCOR PHARMACEUTICALS INC | Director | Awarded | 4,183 | 14,183 | SEC | ||
| Aug 2, 2012 | Aug 2, 2012 | COMARCO INC | Director | AwardedRight to buy | 250,000 | 250,000 | SEC | ||
| May 10, 2012 | May 14, 2012 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedStock Option (right to purchase) | 15,214 | 15,214 | SEC | ||
| May 20, 2011 | May 23, 2011 | QUESTCOR PHARMACEUTICALS INC | Director | Exercised or settledStock Option (Right to Buy) | 10,000 | 13,333 | SEC | ||
| May 20, 2011 | May 23, 2011 | QUESTCOR PHARMACEUTICALS INC | Director | Exercised options | 10,000 | $4.19 | $42k | 10,000 | SEC |
| Jan 1, 2011 | Jan 4, 2011 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedSTOCK OPTION (Right to Buy) | 32,500 | 10,000 | SEC | ||
| Jul 1, 2010 | Jul 16, 2010 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedSTOCK OPTION (Right to Buy) | 3,750 | 3,750 | SEC | ||
| May 28, 2010 | Jun 2, 2010 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedSTOCK OPTION (Right to Buy) | 10,000 | 10,000 | SEC | ||
| Jan 1, 2010 | Jan 4, 2010 | QUESTCOR PHARMACEUTICALS INC | Director | AwardedSTOCK OPTION (Right to Buy) | 15,000 | 15,000 | SEC |
Page 1
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Aug 12, 2021 | STAA | Director | Form 4 sale | 29,921 | $4.4M | 91.1% | Unusual | SEC |
| Mar 1, 2021 | Mar 3, 2021 | STAA | Director | Form 4 sale | 23,996 | $2.5M | 91.9% | Unusual | SEC |
| Apr 7, 2014 | Apr 9, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $846k | 41.4% | Unusual | SEC |
| Jun 12, 2007 | Jun 13, 2007 | NEXTGEN HEALTHCARE, INC. | Chief Executive Officer | Form 4 sale | 2,700 | $104k | 7.3% | Plan not stated | SEC |
| Jun 12, 2007 | Jun 13, 2007 | NEXTGEN HEALTHCARE, INC. | Chief Executive Officer | Form 4 sale | 82,300 | $3.2M | 70.5% | Unusual | SEC |